April 20, 2022
Kite Receives U.S. FDA Approval of New State-of-the-Art CAR T-Cell Therapy Manufacturing Facility in Maryland
April 19, 2022 12:00 UTC -- Kite’s Global CAR T-Cell Therapy Manufacturing Network Increasing…
April 19, 2022
MIMETAS participates in €325 million Oncode-PACT initiative to accelerate and improve oncology drug development
LEIDEN, The Netherlands, April 14, 2022 - MIMETAS, a global leader in organ-on-chip-based disease models,…
